Recombinant Rat MYD88 Protein，His & GST

MYD88 (myeloid differentiation primary response gene 88) is a critical adaptor protein involved in immune signaling pathways, particularly those activated by Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). Its central role in the innate immune response has garnered significant attention, as mutations or dysregulation of MYD88 are associated with various diseases, especially certain hematological malignancies like Waldenström macroglobulinemia and diffuse large B-cell lymphoma. These mutations often lead to constitutive activation of downstream signaling pathways, resulting in enhanced survival and proliferation of malignant cells. Studies have increasingly focused on MYD88's structure and function, aiming to uncover the molecular mechanisms underlying its role in immune responses and cancer. Investigating the recombinant expression of MYD88 protein allows for detailed analysis of its interactions with various ligands and downstream signaling molecules. By studying MYD88 in a controlled setting, researchers hope to elucidate its function in both healthy and diseased states and to identify potential therapeutic targets. As a result, MYD88 has emerged as a focal point in both immunology and oncology research, with promising implications for the development of targeted therapies that could disrupt its aberrant signaling in disease contexts.